Premium
Combined use of NSAIDs and SSRIs increases the risk for gastrointestinal adverse effects
Author(s) -
De Jong Jeroen C. F.,
Brouwers Jacobus R. B. J.,
De Jongvan den Berg Lolkje T. W.
Publication year - 2005
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2005.2212_2.x
Subject(s) - fluvoxamine , sertraline , diclofenac , adverse effect , medicine , fluoxetine , cyp2d6 , naproxen , paroxetine , rofecoxib , pharmacology , piroxicam , relative risk , anesthesia , antidepressant , serotonin , cyclooxygenase , confidence interval , biochemistry , chemistry , receptor , alternative medicine , cytochrome p450 , metabolism , pathology , hippocampus , enzyme